Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Fujisawa discloses vasopressin antagonists

Sep. 6, 1996

CPC-111 clinical trial results disclosed

Aug. 30, 1996

MHC-II and related molecules for treating septic shock

Aug. 30, 1996

Kirin Brewery synthesizes agents for arteriosclerosis

Aug. 30, 1996

Endothelin converting enzyme inhibitor revealed by Schering-Plough

Aug. 30, 1996

BTG and the New England Medical Center sign marketing agreement

Aug. 23, 1996

Santen reveals neutral endopeptidase inhibitors

Aug. 23, 1996

BMS-186716: Bristol-Myers Squibb's ACE/neutral endopeptidase inhibitor

Aug. 23, 1996

Carvedilol approved for CHF indication in Spanish market

Aug. 23, 1996

Adenosine reuptake inhibitors from Kyowa Hakko

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...